一种有效的方法,以促进个性化和精确的药物治疗精神分裂症治疗基于药物基因组学
Xiong Zhang1, Xiaoping Gu2, Chengchen Huang2
1Hulunbuir Mental Health Center, Yakeshi, China.
Psychiatry and clinical psychopharmacology
|May 20, 2024
概括
这项研究表明,药物基因组计划可以改善精神分裂症的治疗. 基因检测指导抗精神病药物选择,导致显著的症状减轻和个性化医学的更好的患者结果.
科学领域:
- 药物基因组学 药物基因组学
- 精神病学是一个精神病学.
- 遗传学 是一个遗传学.
背景情况:
- 精神分裂症影响全球人口的0.3-0.7%.
- 这是一种复杂的遗传疾病,受到常见和罕见变异的影响.
- 目前的治疗方法可以通过个性化医疗来改进.
研究的目的:
- 开发和测试用于精神分裂症治疗的药物基因组计划.
- 为了利用MassARRAY飞行时间质谱测量用于基因型.
- 为个性化精神分裂症治疗指导抗精神病药物选择.
主要方法:
- 使用MassARRAY的精神分裂症患者的基因定型.
- 开发基于遗传变异的药物推报告.
- 在254名精神分裂症患者中进行了观察性临床研究.
- 24周的随访,通过PANSS分数评估症状严重程度.
主要成果:
- 在所有完成研究的患者中观察到PANSS得分的显著降低.
- 与遗传结果一致的药物治疗患者显示,PANSS得分减少了56.1%.
- 具有"谨慎使用"遗传结果的患者显示,PANSS得分减少了37.6%.
结论:
- 药物基因组程序对于精确的精神分裂症治疗是有效的.
- 基因检测可以指导个性化抗精神病药物选择.
- 这种方法支持精准医学在精神病学中的进步.
相关概念视频
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Drug Therapy
42
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
42
Psychosis: Goals of Pharmacotherapy
123
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
123
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
580
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
580
Psychosis and Antipsychotic Drugs: Overview
236
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
236
Biological Causes of Schizophrenia
55
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
55


